- Home
- TECX vs GSRT Comparison
TECX vs GSRT Comparison
Compare TECX & GSRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TECX
- GSRT
- Stock Information
- Founded
- TECX 2019
- GSRT 2023
- Country
- TECX United States
- GSRT United States
- Employees
- TECX N/A
- GSRT N/A
- Industry
- TECX
- GSRT
- Sector
- TECX
- GSRT
- Exchange
- TECX Nasdaq
- GSRT Nasdaq
- Market Cap
- TECX 334.4M
- GSRT 316.5M
- IPO Year
- TECX 2018
- GSRT 2024
- Fundamental
- Price
- TECX $21.09
- GSRT $10.77
- Analyst Decision
- TECX Buy
- GSRT
- Analyst Count
- TECX 6
- GSRT 0
- Target Price
- TECX $78.67
- GSRT N/A
- AVG Volume (30 Days)
- TECX 243.5K
- GSRT 1.3M
- Earning Date
- TECX 08-13-2025
- GSRT 01-01-0001
- Dividend Yield
- TECX N/A
- GSRT N/A
- EPS Growth
- TECX N/A
- GSRT N/A
- EPS
- TECX N/A
- GSRT 0.14
- Revenue
- TECX N/A
- GSRT N/A
- Revenue This Year
- TECX N/A
- GSRT N/A
- Revenue Next Year
- TECX N/A
- GSRT N/A
- P/E Ratio
- TECX N/A
- GSRT $76.13
- Revenue Growth
- TECX N/A
- GSRT N/A
- 52 Week Low
- TECX $13.70
- GSRT $9.86
- 52 Week High
- TECX $61.07
- GSRT $11.49
- Technical
- Relative Strength Index (RSI)
- TECX 50.45
- GSRT N/A
- Support Level
- TECX $19.13
- GSRT N/A
- Resistance Level
- TECX $20.75
- GSRT N/A
- Average True Range (ATR)
- TECX 1.33
- GSRT 0.00
- MACD
- TECX -0.10
- GSRT 0.00
- Stochastic Oscillator
- TECX 56.73
- GSRT 0.00
About TECX Tectonic Therapeutic Inc. Common Stock
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.
About GSRT GSR III Acquisition Corp. Ordinary Shares
GSR III Acquisition Corp is a blank check company.